receive lactulose (30–60 mL/day) + probiotic (200 million colony forming units of seven bacteria species/day) (Gp-LPr) or probiotic alone (Gp-Pr) or lactulose + placebo (Gp-L)	baseline	psychometric hepatic encephalopathy score (PHES)	1102	1286	PHES significantly improved after medication in all the three groups (Gp-LPr: −3.8 ± 3.9 to −1.6 ± 3.0; Gp-L: −4.8 ± 4.1 to −1.6 ± 2.9; and Gp-Pr: −4.9 ± 3.7 to −2.1 ± 2.5, P < 0.001).
receive lactulose (30–60 mL/day) + probiotic (200 million colony forming units of seven bacteria species/day) (Gp-LPr) or probiotic alone (Gp-Pr)	baseline	psychometric hepatic encephalopathy score (PHES) after 8 weeks	12842	13019	After 8 weeks follow-up, there was a deterioration in the Gp-L (−1.6 ± 2.9 to −4.8 ± 4.2), while the status of the Gp-LPr and Gp-Pr arms did not change significantly [Figure 2].
